Global Blood Therapeutics, Inc. (GBT), relating to its proposed acquisition by Pfizer Inc. Under the terms of the agreement, GBT shareholders are expected to receive $68.50 in cash per share they own.
Global Blood Therapeutics, Inc. (GBT), relating to its proposed acquisition by Pfizer Inc. Under the terms of the agreement, GBT shareholders are expected to receive $68.50 in cash per share they own.